(Q42555489)

English

Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 lev

scientific article published on August 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 lev (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Levine AM

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Tulpule A

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Espina B

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Boswell W

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Buckley J

5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Rasheed S

6

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Stain S

7

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Parker J

8

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Nathwani B

9

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Gill PS

10

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 August 1996

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

78

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

517-526

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Non-Hodgkin's lymphomas in never married men in Los Angeles

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

AIDS-associated non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Increasing incidence of cancers associated with the human immunodeficiency virus epidemic

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

AIDS-associated non-Hodgkin's lymphoma in San Francisco

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

AIDS-related malignant lymphoma: results of prospective treatment trials

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Random-effects models for longitudinal data

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C517%3A%3AAID-CNCR20%3E3.0.CO%3B2-0

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19960801)78:3<517::AID-CNCR20>3.0.CO;2-0

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42555489&oldid=1774593002"